E. Lehmann

862 total citations
40 papers, 451 citations indexed

About

E. Lehmann is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, E. Lehmann has authored 40 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 9 papers in Clinical Psychology. Recurrent topics in E. Lehmann's work include Treatment of Major Depression (9 papers), Schizophrenia research and treatment (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). E. Lehmann is often cited by papers focused on Treatment of Major Depression (9 papers), Schizophrenia research and treatment (8 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers). E. Lehmann collaborates with scholars based in Germany, Israel and Switzerland. E. Lehmann's co-authors include E. Klieser, N Gadoth, Sigmund A. Weitzman, Bernd Strebel, Wolfgang Gäebel, Kurt F. J. Heinrich, J. Tegeler, M.W. Agelink, J Pach and Anja Schweizer and has published in prestigious journals such as Psychopharmacology, Phytomedicine and Journal of Plant Nutrition and Soil Science.

In The Last Decade

E. Lehmann

39 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Lehmann Germany 13 137 136 82 61 56 40 451
Hwei Wuen Chan Singapore 11 129 0.9× 66 0.5× 86 1.0× 30 0.5× 107 1.9× 28 603
Michael Nathan Israel 9 116 0.8× 118 0.9× 55 0.7× 29 0.5× 111 2.0× 15 576
M Fritts United States 8 74 0.5× 107 0.8× 15 0.2× 35 0.6× 43 0.8× 14 361
Hatam Boostani Iran 10 56 0.4× 54 0.4× 44 0.5× 26 0.4× 165 2.9× 23 367
G. Clerc France 7 216 1.6× 49 0.4× 23 0.3× 345 5.7× 33 0.6× 13 565
Jan Bastiaans Netherlands 9 47 0.3× 44 0.3× 36 0.4× 22 0.4× 157 2.8× 25 493
E. Schrader Germany 6 40 0.3× 157 1.2× 54 0.7× 54 0.9× 93 1.7× 7 443
Felicity Adams United States 5 90 0.7× 136 1.0× 18 0.2× 30 0.5× 117 2.1× 5 420
Richard Whale United Kingdom 12 147 1.1× 23 0.2× 12 0.1× 130 2.1× 52 0.9× 32 554
Catherine Transler Netherlands 13 115 0.8× 22 0.2× 158 1.9× 26 0.4× 33 0.6× 15 893

Countries citing papers authored by E. Lehmann

Since Specialization
Citations

This map shows the geographic impact of E. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lehmann more than expected).

Fields of papers citing papers by E. Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lehmann. The network helps show where E. Lehmann may publish in the future.

Co-authorship network of co-authors of E. Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of E. Lehmann. A scholar is included among the top collaborators of E. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Lehmann. E. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agelink, M.W., et al.. (2003). Beeinflusst Akupunktur die autonom kardiale Regulation bei Patienten mit leichten depressiven Episoden oder Angststörungen?. Fortschritte der Neurologie · Psychiatrie. 71(3). 141–149. 23 indexed citations
2.
Strebel, Bernd, et al.. (2000). Einstellungen von Studierenden der Medizin zur Psychiatrie. Der Nervenarzt. 71(3). 205–212. 22 indexed citations
3.
Lehmann, E., et al.. (1997). Drug Monitoring Studies as a Method of Analyzing Response Criteria. Pharmacopsychiatry. 30(S 1). 52–56. 1 indexed citations
4.
Wurthmann, C., E. Klieser, E. Lehmann, & J. Krauth. (1996). Single-Subject Experiments to Determine Individually Differential Effects of Anxiolytics in Generalized Anxiety Disorder. Neuropsychobiology. 33(4). 196–201. 6 indexed citations
5.
Klieser, E., E. Lehmann, & Kurt F. J. Heinrich. (1995). Fluoxetine in Patients with Major Depressive Disorder - A Responder Analysis. Pharmacopsychiatry. 28(1). 14–19. 17 indexed citations
6.
Wurthmann, C., et al.. (1995). Psychopharmakologische Differentialtherapie generalisierter Angststörungen - Ergebnisse einer Studie mit 30 Einzelfallexperimenten. Fortschritte der Neurologie · Psychiatrie. 63(8). 303–309. 3 indexed citations
7.
Wurthmann, C., et al.. (1995). Interaktion von therapeutischen Wirkungen und Nebenwirkungen in der Pharmakotherapie generalisierter Angststörungen mit niedrigdosiertem Fluspirilen. Fortschritte der Neurologie · Psychiatrie. 63(2). 72–77. 2 indexed citations
8.
Kanowski, S., et al.. (1995). Confirmed Clinical Efficacy of Actovegin®in Elderly Patients with Organic Brain Syndrome. Pharmacopsychiatry. 28(4). 125–133. 24 indexed citations
9.
Lehmann, E., et al.. (1993). Drug Monitoring Study (Phase IV) of Xantinolnicotinate (Complamin®) in General Practice. Pharmacopsychiatry. 26(2). 42–48. 4 indexed citations
10.
Klieser, E. & E. Lehmann. (1992). Zur Streitfrage der standardisierten Haloperidolbehandlungen im Vergleich zur ,,adäquaten individuellen Dosierung" bei akut erkrankten schizophrenen Patienten. Fortschritte der Neurologie · Psychiatrie. 60(3). 126–129. 2 indexed citations
11.
Klieser, E., et al.. (1991). Doppelblindvergleich von 3 × 75 mg Zotepin und 3 × 4 mg Haloperidol bei akut schizophrenen Patienten. Fortschritte der Neurologie · Psychiatrie. 59(S 1). 14–17. 18 indexed citations
12.
Tegeler, J., et al.. (1990). Safety of Long-Term Neuroleptanxiolysis with Fluspirilene 1.5 mg per Week. Pharmacopsychiatry. 23(6). 259–264. 4 indexed citations
13.
Tegeler, J., et al.. (1990). Double-blind Study of the Therapeutic Efficacy and Tolerability of Amitriptylinoxide in Comparison with Amitriptyline. Pharmacopsychiatry. 23(1). 45–49. 6 indexed citations
14.
Lehmann, E., et al.. (1989). The Efficacy of Cavain in Patients Suffering from Anxiety. Pharmacopsychiatry. 22(6). 258–262. 10 indexed citations
15.
Klieser, E. & E. Lehmann. (1989). Experimental Examination of Trazodone. Clinical Neuropharmacology. 12. S18–S24. 16 indexed citations
16.
Lehmann, E.. (1989). The Dose-Effect Relationship of 0.5, 1.0 and 1.5 mg Fluspirilene on Anxious Patients. Neuropsychobiology. 21(4). 197–204. 4 indexed citations
17.
18.
Lehmann, E., et al.. (1984). Differential improvements from haloperidol in two types of schizophrenics. Psychopharmacology. 84(1). 96–97. 8 indexed citations
19.
Kopeć, Ada C., et al.. (1973). IX. The hereditary blood factors of the Yemenite and Kurdish Jews. PubMed. 266(876). 169–184. 13 indexed citations
20.
Lehmann, E., et al.. (1973). II. A clinical survey of Yemenite and Kurdish Jews in Israel. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 266(876). 97–100. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hwei Wuen Chan Breakdown of academic impact, for papers by Michael Nathan Breakdown of academic impact, for papers by M Fritts Breakdown of academic impact, for papers by Hatam Boostani Breakdown of academic impact, for papers by G. Clerc Breakdown of academic impact, for papers by Jan Bastiaans Breakdown of academic impact, for papers by E. Schrader Breakdown of academic impact, for papers by Felicity Adams Breakdown of academic impact, for papers by Richard Whale Breakdown of academic impact, for papers by Catherine Transler
Rankless by CCL
2026